ויפנד 50 מג טבליות מצופות Israel - hebraisk - Ministry of Health

ויפנד 50 מג טבליות מצופות

pfizer pfe pharmaceuticals israel ltd - voriconazole - טבליות מצופות פילם - voriconazole 50 mg - voriconazole - voriconazole - treatment of: invasive aspergillosis, fluconazole-resistant serious invasive candida infections (including c. krusei) serious fungal infections caused by scedosporium spp. and fusarium spp. vfend should be administered primarily to immunocompromised patients with progressive possibly life-threatening infections. treatment of candidemia in non neutropenic patients.

ויפנד 200 מג אבקה להכנת תמיסה לעירוי Israel - hebraisk - Ministry of Health

ויפנד 200 מג אבקה להכנת תמיסה לעירוי

pfizer pfe pharmaceuticals israel ltd - voriconazole - אבקה להכנת תמיסה לאינפוזיה - voriconazole 200 mg/vial - voriconazole - voriconazole - treatment of :- invasive aspergillosis fluconazole-resistant serious invasive candida infections (including c. krusei) , - serious fungal infections caused by scedosporium spp. and fusarium spp.vfend should be administered primarily to immunocompromised patients with progressive possibly life-threatening infections. treatment of candidemia in non neutropenic patients.

ויפנד 40 מגמל אבקה להכנת תרחיף למתן דרך הפה Israel - hebraisk - Ministry of Health

ויפנד 40 מגמל אבקה להכנת תרחיף למתן דרך הפה

pfizer pfe pharmaceuticals israel ltd - voriconazole - אבקה להכנת תרחיף - voriconazole 40 mg/ml - voriconazole - voriconazole - treatment of : invasive aspergillosis, fluconazole-resistant serious invasive candida infections (including c. krusei) , serious fungal infections caused by scedosporium spp. and fusarium spp.vfend should be administered primarily to immunocompromised patients with progressive possibly life-threatening infections. treatment of candidemia in non neutropenic patients.

פלוקונאזול טבע   150 מג Israel - hebraisk - Ministry of Health

פלוקונאזול טבע 150 מג

abic marketing ltd, israel - fluconazole - קפסולות - fluconazole 150 mg - fluconazole - fluconazole - cryptococcosis. - systemic candidiasis. - mucosal candidiasis. - vaginal candidiasis. - dermatomycosis.

נוקספיל תרחיף Israel - hebraisk - Ministry of Health

נוקספיל תרחיף

merck sharp & dohme israel ltd - posaconazole - תרחיף - posaconazole 40 mg/ml - posaconazole - posaconazole - noxafil is indicated for use in the treatment of the following fungal infections in adults : - invasive aspergillosis in patients with disease that is refractory to amphotericin b or itraconazole or in patients who are intolerant of these medicinal products - fusariosis in patients with disease that is refractory to amphotericin b or in patients who are intolerant of amphotericin b - chromoblastomycosis and mycetoma in patients with disease that is refractory to itraconazole or in patients who are intolerant of itraconazole - coccidioidomycosis in patients with disease that is refractory to amphotericin b itraconazole or fluconazole or in patients who are intolerant of these medicinal products - oropharyngeal candidiasis : as first - line therapy in patients who have severe disease or are immunocompromised in whom response to topical therapy is expected to be poor. refractoriness is defined as progression of infection or failure to improve after a minimum of 7 days of prior therapeutic doses of effective anti

אלימטה 500 מג Israel - hebraisk - Ministry of Health

אלימטה 500 מג

eli lilly israel ltd, israel - pemetrexed - אבקה להכנת תמיסה לאינפוזיה - pemetrexed 500 mg/vial - pemetrexed - pemetrexed - alimta in combination with cisplatin is indicated for the treatment of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curatible surgery. alimta in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. alimta is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.alimta is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy.

אלימטה 500 מג Israel - hebraisk - Ministry of Health

אלימטה 500 מג

eli lilly israel ltd, israel - pemetrexed - אבקה להכנת תמיסה לאינפוזיה - pemetrexed 500 mg/vial - pemetrexed - pemetrexed - alimta in combination with cisplatin is indicated for the treatment of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curatible surgery. alimta in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. alimta is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.alimta is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy.

נוקספיל תרחיף Israel - hebraisk - Ministry of Health

נוקספיל תרחיף

merck sharp & dohme (israel - 1996) company ltd, israel - posaconazole - תרחיף - posaconazole 40 mg/ml - posaconazole - posaconazole - noxafil is indicated for use in the treatment of the following fungal infections in adults : - invasive aspergillosis in patients with disease that is refractory to amphotericin b or itraconazole or in patients who are intolerant of these medicinal products - fusariosis in patients with disease that is refractory to amphotericin b or in patients who are intolerant of amphotericin b - chromoblastomycosis and mycetoma in patients with disease that is refractory to itraconazole or in patients who are intolerant of itraconazole - coccidioidomycosis in patients with disease that is refractory to amphotericin b itraconazole or fluconazole or in patients who are intolerant of these medicinal products - oropharyngeal candidiasis : as first - line therapy in patients who have severe disease or are immunocompromised in whom response to topical therapy is expected to be poor. refractoriness is defined as progression of infection or failure to improve after a minimum of 7 days of prior therapeutic doses of effective anti

ניזורל קרם Israel - hebraisk - Ministry of Health

ניזורל קרם

devries & co. ltd - ketoconazole - קרם - ketoconazole 20 mg/g - ketoconazole - ketoconazole - nizoral cream is indicated for topical application in the treatment of dermatophyte infections of the skin: tinea corporis, tinea cruris, tinea manus and tinea pedis due to trichophyton rubrum, microsporum canis and epidermophyton floccosum, as well as in the treatment of cutaneous candidosis and tinea (pityriasis ) vesicolor. nizoral cream is also indicated for the treatment of seborrheic dematitis caused by pityrosporum sp.

טרבינאפין טבע 250 מג Israel - hebraisk - Ministry of Health

טרבינאפין טבע 250 מג

teva israel ltd - terbinafine as hydrochloride - קפליות - terbinafine as hydrochloride 250 mg - terbinafine - terbinafine - fungal infections of the skin caused by dermatophytes such as trichophyton (e.g. rubrum, t. mentagrophytes, t. verrucosum, t. violaceum), microsporum canis and epidermophyton floccosum. oral terbinafine should only be used to treat extensive, severe ringworm infections ( tinea corporis, tinea cruris and tinea pedis). oral terbinafine is not effective against vaginal candidiasis or pityriasis (tinea) versicolor.onychomycoses ( tinea unguium, ringworm of the nails) due to infection with dermatophyte organisms ( hyphomycetes).